Fig. 6: Iron supplementation reverses the HIF1α-stabilizing and DNA damage-inducing activities of PAC-1.

a, b HIF1α stabilization status in HIF1α-EGFP_CHO cells after 3 h of treatment (PAC-1 concentration: 30 μM). c, d RAD51 and pH2AX levels in RAD51-EGFP_SW480 cells after 24 h of treatment with 30 μM PAC-1 with or without FeCl2 supplementation. e Cell cycle distribution status in HepG2 cells after the indicated treatments for 24 h. Data represent means ± SEs of three independent experiments